XLO

UNKNOWN

Xilio Therapeutics, Inc.

CIK: 0001840233

Buy (50% confidence)

Last activity: 1 weeks ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $43.77M

Total Cash $120.39M

Insider	Buys	Sells	Net Value	Holdings
Shannon James Samuel OTHER	1	0	$44K	10,000 shares $88K
Frankenfield Christopher James Chief Financial Officer	0	1	-$5K	24,766 shares $16K
Brennan Kevin M. SVP, FINANCE AND ACCOUNTING	0	1	-$1K	6,371 shares $4K

BUY Shannon James Samuel (OTHER)

5,000 shares @ $8.79

$44K

Mar 26, 2026

Conviction: | View SEC Filing →

SELL Frankenfield Christopher James (Chief Financial Officer)

7,030 shares @ $0.64

$5K

Jan 2, 2026

Conviction: | View SEC Filing →

SELL Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING)

1,826 shares @ $0.64

$1K

Jan 2, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.